Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
American Journal of Nuclear Medicine and Molecular Imaging
|
July 17, 2023
Co-injection of anti-HER2 antibody Trastuzumab does not increase efficacy of [<sup>177</sup>Lu]Lu-PSMA-617 therapy in an animal model of prostate cancer
Ayman Abouzayed, Wahed Zedan, Mohamed Altai, et al.
Antioxidants (Basel, Switzerland)
|
August 27, 2021
Kidney Protection with the Radical Scavenger α<sub>1</sub>-Microglobulin (A1M) during Peptide Receptor Radionuclide and Radioligand Therapy
Amanda Kristiansson, Anders Örbom, Oskar Vilhelmsson Timmermand, et al.
Scientific Reports
|
May 11, 2024
Hematological and renal toxicity in mice after three cycles of high activity [<sup>177</sup>Lu]Lu-PSMA-617 with or without human α<sub>1</sub>-microglobulin
Amanda Kristiansson, Oskar Vilhelmsson Timmermand, Mohamed Altai, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
November 28, 2024
Intratumoral Distribution of [<sup>177</sup>Lu]Lu-PSMA-617 Over Time and in Relation to Diagnostic Tracers in Animal Models of Prostate Cancer
Anders Örbom, Joanna Strand, Mohamed Altai, et al.
Pharmaceutics
|
April 23, 2022
Hematological Toxicity in Mice after High Activity Injections of <sup>177</sup>Lu-PSMA-617
Amanda Kristiansson, Oskar Vilhelmsson Timmermand, Mohamed Altai, et al.
Frontiers in Physiology
|
July 9, 2020
Imaging Biomarkers and Pathobiological Profiling in a Rat Model of Drug-Induced Interstitial Lung Disease Induced by Bleomycin
Irma Mahmutovic Persson, Hanna Falk Håkansson, Anders Örbom, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
February 25, 2025
Heterogeneous Distribution and Absorbed Dose of Radiolabeled Nanoparticles and Colloids in Sentinel Lymph Nodes
Renata Madru, Erik Larsson, Anders Örbom, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 28, 2013
The intratumoral distribution of radiolabeled 177Lu-BR96 monoclonal antibodies changes in relation to tumor histology over time in a syngeneic rat colon carcinoma model
Anders Örbom, Sophie E Eriksson, Erika Elgström, et al.
Nuklearmedizin. Nuclear Medicine
|
March 18, 2025
Intratumoral distribution and pharmacokinetics of the radiolabeled ICAM-1 targeting monoclonal antibody R6.5 in a prostate cancer mouse model
Anders Örbom, Susan Evans-Axelsson, Bo Jansson, et al.
Frontiers in Medicine
|
April 24, 2024
<i>In vivo</i> MRI and PET imaging in a translational ILD mouse model expressing non-resolving fibrosis and bronchiectasis-like pathology after repeated systemic exposure to bleomycin
Irma Mahmutovic Persson, Nina Fransén Petterson, Jian Liu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
American Journal of Nuclear Medicine and Molecular Imaging
|
July 17, 2023
Co-injection of anti-HER2 antibody Trastuzumab does not increase efficacy of [<sup>177</sup>Lu]Lu-PSMA-617 therapy in an animal model of prostate cancer
Ayman Abouzayed, Wahed Zedan, Mohamed Altai, et al.
Antioxidants (Basel, Switzerland)
|
August 27, 2021
Kidney Protection with the Radical Scavenger α<sub>1</sub>-Microglobulin (A1M) during Peptide Receptor Radionuclide and Radioligand Therapy
Amanda Kristiansson, Anders Örbom, Oskar Vilhelmsson Timmermand, et al.
Scientific Reports
|
May 11, 2024
Hematological and renal toxicity in mice after three cycles of high activity [<sup>177</sup>Lu]Lu-PSMA-617 with or without human α<sub>1</sub>-microglobulin
Amanda Kristiansson, Oskar Vilhelmsson Timmermand, Mohamed Altai, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
November 28, 2024
Intratumoral Distribution of [<sup>177</sup>Lu]Lu-PSMA-617 Over Time and in Relation to Diagnostic Tracers in Animal Models of Prostate Cancer
Anders Örbom, Joanna Strand, Mohamed Altai, et al.
Pharmaceutics
|
April 23, 2022
Hematological Toxicity in Mice after High Activity Injections of <sup>177</sup>Lu-PSMA-617
Amanda Kristiansson, Oskar Vilhelmsson Timmermand, Mohamed Altai, et al.
Frontiers in Physiology
|
July 9, 2020
Imaging Biomarkers and Pathobiological Profiling in a Rat Model of Drug-Induced Interstitial Lung Disease Induced by Bleomycin
Irma Mahmutovic Persson, Hanna Falk Håkansson, Anders Örbom, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
February 25, 2025
Heterogeneous Distribution and Absorbed Dose of Radiolabeled Nanoparticles and Colloids in Sentinel Lymph Nodes
Renata Madru, Erik Larsson, Anders Örbom, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 28, 2013
The intratumoral distribution of radiolabeled 177Lu-BR96 monoclonal antibodies changes in relation to tumor histology over time in a syngeneic rat colon carcinoma model
Anders Örbom, Sophie E Eriksson, Erika Elgström, et al.
Nuklearmedizin. Nuclear Medicine
|
March 18, 2025
Intratumoral distribution and pharmacokinetics of the radiolabeled ICAM-1 targeting monoclonal antibody R6.5 in a prostate cancer mouse model
Anders Örbom, Susan Evans-Axelsson, Bo Jansson, et al.
Frontiers in Medicine
|
April 24, 2024
<i>In vivo</i> MRI and PET imaging in a translational ILD mouse model expressing non-resolving fibrosis and bronchiectasis-like pathology after repeated systemic exposure to bleomycin
Irma Mahmutovic Persson, Nina Fransén Petterson, Jian Liu, et al.
Page
of 2